Maternal Serum Progesterone And Estradiol During Pregnancy And Childbirth – What Has The Literature Taught Us So Far?

Pappa C, Dosiou K and Kitsouli A

Published on: 2023-02-08

Abstract

Pregnancy and childbirth comprise a complex multifactorial succession of events involving mechanical, inflammatory and endocrine stimuli deriving from the fetal, placental and maternal compartments. Despite extensive research, the precise mechanism of transition from myometrial quiescence to the contractile myometrial state of parturition, remains still to be elucidated. Progesterone and estradiol are known to play a vital role in the maintenance of pregnancy and the cascading process of parturition. However, to further clarify the rationale behind this dynamic balance between gestation and childbirth, we initially need to evaluate the ‘baseline normal’ levels of maternal serum progesterone and estradiol and their fluctuation during uncomplicated pregnancy and labour. This article aims to review the most comprehensive publications that present and analyze the maternal serum progesterone and oestradiol levels and their patterns during low-risk pregnancy and successful childbirth.

Keywords

Childbirth; Pregnancy; Gestation; Serum progesterone; Serum estradiol; Hormonal fluctuation in pregnancy; Hormonal fluctuation in parturition

Introduction

During the latest years, a significant part of the worldwide bibliography refers to the rising prevalence rates of gestational complications linked to various endocrine disruptions. [1-3] However, the ‘normal pattern’ of hormonal fluctuations during uncomplicated pregnancy and childbirth remains unclear.

Indubitably, progesterone and oestradiol represent two of the most crucial hormonal regulators in human reproduction with their effect being present from the very early stage of conception up to the postpartum period. [4-7].

Progesterone is an endogenous female steroid hormone naturally secreted by the corpus luteum in the ovaries. [8] After the first 7-10 weeks of pregnancy, the secretion of progesterone is accomplished by the placenta. [6] Its role has been proven to be vital in pregnancy including: (a). the preparation of the endometrium to accommodate the implantation of the blastocyst, (b). the maintenance of myometrial quiescence to promote the normal gestation and fetal growth, (c). the stimulation of maternal breast growth along with the inhibition of lactation until delivery and (d). the mucosal thickening of the cervix to prevent intrauterine infection [9,10].

On the other hand, oestradiol represents another endogenous steroid hormone secreted by the ovarian follicles, the adrenal glands, the fat tissue, the liver, the mammary glands, and the pituitary. [11] During pregnancy its levels increase due to the placental secretion. Its role is to prepare the endometrium for the implantation by promoting the endometrial thickening, to amplify the events which lead to increased blood supply in the uterus, to prepare the female mammary glands for the lactation and towards the end to promote the cervical softening and expression of myometrial oxytocin receptors [12,13].

Both progesterone and estradiol also play a fundamental role in the regulation of childbirth. [11] Years of research have shown that progesterone prevents preterm labour by promoting myometrial quiescence until the completion of fetal maturity, while estradiol comprises the main molecular-hormonal signal for the initiation of parturition [8,14].

Purpose And Methods

The aim of this paper is to review comprehensive studies reporting on the levels of maternal serum progesterone and estradiol and their fluctuation during pregnancy and childbirth [15].

Studies published between January 1972 and December 2022 were identified and retrieved from searches of Medline Database, PubMed Database, CAB Direct database, and Scopus, using the following search terms: ‘childbirth’, ‘labour’ ‘pregnancy’, ‘gestation’, ‘serum progesterone’, ‘serum estradiol’, ‘hormone levels’, ‘gestational hormones’, ‘pregnancy hormones’, ‘hormonal fluctuation in gestation’, hormonal fluctuation in pregnancy’, hormonal fluctuation in parturition’.

Only articles published in English, or having a detailed abstract in English, were included.

Progesterone and Estradiol Levels during Gestation

The role of progesterone in preventing preterm labour has been the center of research for many decades. [16-18] However, there are not many studies investigating the serum progesterone levels during the different pregnancy trimesters.

Maternal estradiol levels gradually increase during a healthy pregnancy reaching their pick levels just before the initiation of parturition [13]. More recent bibliographical sources have presented significant findings that link these levels with various pregnancy outcomes.

However, most of the studies concentrate on the locoregional action of estradiol and progesterone during pregnancy rather than their circulating trajectories and their potential correlation with the tissue interaction and subsequent outcome. [19] Current literature concentrates on various hormonal levels during artificial reproductive techniques and/ or during pregnancy and childbirth complications, placing in second place their fluctuations in low-risk pregnancies.

The median (range) maternal serum progesterone and estradiol levels that have been reported by the different studies so far during low risk pregnancies are presented in table 1.

Table 1: Median (range) progesterone and oestradiol levels in low-risk pregnancies as reported by the different studies.

Progesterone in nmol/L

Study Pregnancy
1st trimester 2nd trimester 3rd trimester
Schock etal. 2016 10-12w 81.41(52.79-129.43) 20-22w 152.95 (100.49-249.63) 35-37w 413.40 (230.86-636.00)
Ku et al. 2018 5w 69.37 (10.65-144.56) - -
6w 57.25 (20.44-109.98) - -
7w 62.47 (29.76-103.51) - -
8w 69.85 (35.36-147.51) - -
9w 80.70 (34.16-174.00) - -
10w 77.52 (34.00-161.16) - -
11w 79.60 (45.43-131.20) - -
12w 97.97 (70.89-169.43) - -
Babdiwala et al. 2022   59.00 (5.00-219.00) -   -  
Pappa et al. 2022 10-12w 246.58(65.50-1,198.54) - >37w 519.89(221.96-1,167.86)

Oestradiol in ng/ml

Study

Pregnancy

1st trimester

2nd trimester

3rd trimester

Schock et al. 2016

10-12w

2.18 (1.16–3.59)

20-22w

9.71 (5.33–15.1)

35-37w

20.4 (12.8–32.9)

Pappa et

10-12w

4.55 (0.63-22.87)

-

>37w

41.13 (5.39-24.58)

al. 2022

w: week of pregnancy

Conversion from ng/mL to nmol/L for progesterone *3.18

 A prospective cohort study published by Ku et al. investigated the serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage, in women from 5 to 13 weeks of gestation. The sample of the study consisted of 929 patients from Singapore, and the pregnancy outcome was decided at 16 weeks of gestation. The median serum progesterone concentration was characterized by a linearly increasing trend from 57.5 nmol/L to 80.8 nmol/L from 5 to 13 weeks gestation in the normal pregnancy cohort, while, in the threatened miscarriage cohort, median serum progesterone concentration increased from 41.7 nmol/L to 78.1 nmol/L. The median progesterone levels, in the threatened miscarriage group were uniformly lower by approximately 10 nmol/L at each gestational week, compared to the normal pregnancy ones. At the same time, the median serum progesterone concentration at 16 weeks of gestation showed a linearly increasing trend from 5 to 13 weeks of gestation in both cohorts, while women with spontaneous miscarriage demonstrated a marginal and non-significant increase in their serum progesterone levels. The aforementioned data emphasize on the significant role of progesterone during early gestation, as lower serum progesterone levels are linked to threatened miscarriage and a subsequent complete miscarriage at 16 weeks of gestation [20].

In March 2020, Deng et al. investigated the baseline levels of serum progesterone in women with threatened miscarriage, during first trimester. Seven hundred twenty-six women with threatened miscarriage were included in the study. The levels of progesterone were statistically associated with the women’s basic demographic data, obstetric history, and clinical information. The results showed that there is a negative correlation between the maternal serum progesterone levels and the first trimester pregnancy outcome. Specifically, when progesterone levels were lower than 90.62 nmol/L, increase in the serum progesterone by 1 nmol/L was associated with a 3% decrease of the risk of miscarriage (OR: 0.97, 95% CI: 0.95-0.98) concluding that there is a higher risk of miscarriage when serum progesterone levels are less than 90.62 nmol/L. Those results do not clearly depict the difference in progesterone levels during the first trimester, however they still reflect the anticipating serum progesterone levels during the first trimester and the potential screening value of maternal serum progesterone levels in the prognosis of the pregnancy outcome [21].

Ku et al. published in February 2021, another interesting primary, cross-sectional study that focused on the normal fluctuations of progesterone blood levels in 590 healthy pregnant women between 5 and 12weeks. The progesterone blood levels were statistically correlated with the women’s age, body mass index (BMI), parity, gestational age, and pregnancy outcomes at 16 weeks. The results proven that, during the first trimester of healthy pregnancy, serum progesterone starts to decline after 5 weeks, reaching their nadir two weeks later, at 7 weeks of gestation. The mean serum progesterone in week 5 was 75.0 nmol/L, compared to 66.9 nmol/L in week 6 (p = 0.057), and 63.4 nmol/L in week 7 (p = 0.029)]. Followed by , an increasing trajectory from 7 to 9 weeks with the mean serum progesterone levels being equal to63.4 nmol/L at 7 weeks, 67.7 nmol/L at 8 weeks (p = 0.374) and 78.9 nmol/L at 9 weeks (p < 0.001) [22].

In January 2022, the secondary analysis of prospective multicentre study data of consecutive women with a pregnancy of unknown location, from Bobdiwala et al., evaluated the predictive value of progesterone, β human chorionic gonadotropin, and β human chorionic gonadotropin ratio cut-off levels to exclude a viable intrauterine pregnancy in women with a pregnancy of unknown location between 11-14 weeks of gestation. Focusing on maternal progesterone levels, with data deriving from 2248 women, the study concluded that the likelihood of viability decreased in correlation with the serum progesterone levels. Analytically, the median progesterone levels associated with viability were 59 nmol/L, and the viable intrauterine pregnancy was identified with levels as low as 5 nmol/L. Again, as with the data of Deng et al. that was mentioned above, these results do not clearly depict the fluctuations of progesterone levels. Nevertheless, they still reflect the anticipated serum progesterone levels during the first trimester of intrauterine pregnancies and can be a useful tool in the prognosis of the pregnancy outcome. [21,23]

A longitudinal study by Schock et al., published in 2016, aimed to investigate the levels of maternal hormone concentrations during 71 uncomplicated pregnancies. Focusing on estradiol levels, the researchers concluded that they were highly correlated with the other hormones of placental origin (estrone and progesterone) (r > 0.72, p < 0.0001), while gestational age was found to be highly correlated with the levels of estradiol (r = 0.89; p < 0.0001). The median estradiol levels during the first, second and third

Trimester were 2.18(1.16- 3.59) ng/mL, 9.71 (5.33- 15.1) ng/mL and 20.4 (12.8- 32.9) ng/mL, respectively. Regarding progesterone levels, the initial median value was 25.6 (16.6- 40.7) ng/mL during the first trimester, increasing to 48.1 (31.6- 78.5) ng/mL in the second half of pregnancy and further raising to 130 (72.6- 200) in the third trimester. Another significant finding was that estradiol concentrations were more strongly correlated between consecutive trimesters of a pregnancy than between the 1st and 3rd trimester (e.g. estradiol, rT1 vs. T2 = 0.51 and rT2 vs. T3 = 0.60, p  <  0.01; rT1 vs. T3 = 0.32, p  <  0.05) [12].

In April 2022, Hu et al. gave to publication another primary study which suggested that high circulating estradiol levels during the first trimester in women with multiple pregnancies, seem to significantly contribute to small for gestational age fetuses, and more specifically, that this contribution is accomplished via DNA methyltransferase 1 (DNMT1)-mediated cyclin dependent kinase inhibitor 1C (CDKN1C) upregulation [24]. The researchers found that at 8 weeks of gestation the maternal serum estradiol tend to rise with the number of fetuses and seem to be negatively correlated with the newborns’ birth weight [25].

Few months later, Pappa et al, analyzed the maternal serum progesterone and estradiol levels in 304 nulliparous women during the first trimester between 10 and 12 weeks, at the time of admission before childbirth and intrapartum during the 2nd stage of labour. Women were divided in three different groups according to the way of delivery. There was a significant increase in the progesterone and oestradiol levels during pregnancy among all the three groups. Analytically, progesterone levels increased by a mean value of 109.77 ± 85.39 ng/mL in the natural delivery group, 84.89 ± 71.71 ng/mL in the instrumental delivery group and 63.20 ± 41.42 ng/mL in the caesarean section after failure to progress (FTP) group. Estradiol levels were also found to increase by a mean value of 15,031 ± 5,959 pg/mL, 12,063 ± 5,695 pg/mL and 12,970 ± 6,899 pg/mL in the normal delivery, instrumental delivery and Caesarean section (FTP) cohort, respectively [26].

Progesterone and Oestradiol Levels during Parturition

Research focusing exclusively on maternal serum progesterone and estradiol levels during parturition dates to several decades.

Since June 1978, Boroditsky et al. measured the maternal serum estrone (E1), oestradiol (E2), estriol (E3) and progesterone concentrations during the last 3-10 weeks of healthy pregnancy. The results analysis showed that all estrogens and progesterone levels showed a small diurnal variation during gestation, did not change during labor and significantly declined after delivery [27].

In 1997, Löfgren et al, shown that progesterone concentrations in maternal and umbilical serum were higher following normal labour than after dystocia (p < 0.005) and elective Caesarean section (p < 0.005). The maternal progesterone levels in dystocia and elective Caesarean section accounted between 77-43% of those in normal labour, concluding that high progesterone concentrations during parturition appear to be related to effective labour [28].

A primary study coming from Tan et al. in 2012, explained how two different progesterone receptors on myometrial cells; progesterone receptor-A (PR-A) and -B (PR-B), have opposite effects on pro-inflammatory gene expression, subsequently affecting the initiation of the parturition in healthy women. The researchers analyze the main pre-labour signals, including intra-uterine infection, uterine distention, the increase in fetal prostaglandins, the rupture of membranes and severe haemorrhage. Moreover, they suggest that the different expression of PR-A and PR-B genes, ensure that the responsiveness of the myometrial cells to pre-inflammatory stimuli will be adequate, for the parturition to start [29].

In the same direction, Vrachnis et al. investigated the contribution of progesterone and CRH in the initiation of the labor, in healthy pregnant women. The researchers mentioned the “progesterone block” hypothesis, according to which progesterone prevents contractions of the myometrium during gestation facilitating the continuation of pregnancy, while its withdrawal which is mediated by the regulated co-expression of the receptor genes PR-A and PR-B described by Tan et al., transforms the myometrium from a state of quiescence to the active state required for the initiation of the parturition [29,30].

One year later, Konopka et al investigated whether labour induction with dinoprostone is associated with changes in maternal serum progesterone, oestradiol, and estriol levels. Eighty-one women with term pregnancies were included in the study. Sixteen had vaginal birth after spontaneous labour, 12 required caesarean section after spontaneous labour and 16 underwent elective caesarean. Thirty-seven patients had labour induction with dinoprostone. Serum concentrations were measured at admission and immediately before birth in patients with and without dinoprostone induction. Progesterone levels were decreased from admission to birth in patients who underwent successful labour induction with dinoprostone [vaginal and caesarean birth after induced labour: 23% (P < 0.001) and 18% (P < 0.025) decrease, respectively], but not in those whose induction failed (6.4% decrease, P > 0.05). Oestradiol levels have shown no difference between the different groups. The researchers concluded that successful dinoprostone-induced labour was associated with reduced maternal progesterone levels from induction to birth, proposing also a potential mechanism by which the use of dinoprostone could contribute in progesterone withdrawal [31].

Recently, Pappa et al., in the same study mentioned above, found significant variations in the levels of maternal progesterone and oestradiol levels during the different modes of childbirth. The study has shown that there is a statistically significant difference at the mean of oestradiol and progesterone range during different delivery modes (p-value< .01). Patients who underwent normal delivery had higher intrapartum values of oestradiol (54,486.47 ± 19,665.84 pg/mL) compared to patients who underwent instrumental delivery (44,431.55 ± 16,712.47 pg/mL), and patients who had an operational birth had higher values of oestradiol range compared to patients who underwent Caesarean section (FTP) (24,480.10 ± 7964.98 pg/mL). Regarding progesterone levels, patients who underwent Caesarean section (FTP) had higher values of progesterone during labour (379.90 ± 91.37 ng/mL), compared to patients who delivered normally (196.64 ± 88.10 ng/mL). Women who underwent instrumental delivery, showed the lowest values of progesterone during childbirth (182.44 ± 71.42 ng/mL) [26].

Conclusions and Future Direction

Human childbirth epitomizes the harmonical synchronization of events taking place in three different compartments: the fetal, placental and maternal. [32,33] To date, robust evidence deriving from animal studies has shown that the fetoplacental unit plays the most significant role in the initiation of parturition, with the fetal hypothalamic- pituitary-adrenal (HPA) axis providing the initial impulse for parturition. [34-37] In humans, progesterone and estradiol have attracted much scientific interest as key regulators showing significant fluctuation during the three trimesters of pregnancy and labour, before acutely decrease in the postpartum period. [11,33] In that direction, most of the recent studies reach to the consensus that successful childbirth is the outcome of the cascading process which begins with a stimulus from fetal cortisol secretion and develops through the dynamic balance between the increased estrogen bioavailability and the functional progesterone withdrawal. [7,38] However, yet controversial evidence exists regarding the actual hormonal patterns and levels that regulate the uncomplicated pregnancy and childbirth.

The rapid development of computational biochemistry and analytical techniques has opened new horizons in research by enabling a deeper understanding of the results and offering the ability to simulate data to a better accuracy. Aiming to broaden the conception of the correlation between the maternal hormonal status and the pregnancy outcome, it is imperative to conduct further multicentre prospective studies to investigate and clarify the anticipated values and potential cut-off levels of serum hormonal concentrations in successful uncomplicated pregnancy and childbirth. In the long run, those values can direct future research to evaluate prognostic risk factors and potential benefits and implement assessment protocols in the decision-making process.

Conflict Of Interest

The authors have no conflicts of interest or financial disclosures to declare.

References

  1. Troisi R, Bjorge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, et al. The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med. 2018; 283: 430-445.
  2. KodogoV, Azibani F, Sliwa K. Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review. Clin Res Cardiol. 2019; 108: 831-846.
  3. Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, et al., Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab. 2009; 94: 2066-2074.
  4. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012; 62: 263-271.
  5. Shah NM, Lai PF, Imami N, Johnson MR. Progesterone-Related Immune Modulation of Pregnancy and Labor. Front Endocrinol. 2019; 10: 198.
  6. Tal and H. S. Taylor, ‘Endocrinology of Pregnancy’, in Endotext, K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W. W. de Herder, K. Dhatariya, K. Dungan, J. M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C. S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, E. A. McGee, R. McLachlan, J. E. Morley, M. New, J. Purnell, R. Sahay, F. Singer, M. A. Sperling, C. A. Stratakis, D. L. Trence, and D. P. Wilson, Eds. South Dartmouth (MA): MDText.com, Inc., 2000. Accessed: Jan. 21, 2023.
  7. Mesiano S, Welsh TN. Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol. 2007; 18: 321-331.
  8. Kota SK, Gayatri K, Jammula S, Kota SK, Krishna SVS, Meher LK, et al. Endocrinology of parturition. Indian J Endocrinol Metab. 2013; 17: 50-59.
  9. Goletiani NV, Keith DR, Gorsky SJ. Progesterone: review of safety for clinical studies. Exp Clin Psychopharmacol. 2007; 15: 427-444.
  10. Kumar P, Magon N. Hormones in pregnancy. J Niger Med Assoc. 2012; 53: 179-183.
  11. Vannuccini S, Bocchi C, Severi FM, Challis JR, Petraglia F. Endocrinology of human parturition. Ann Endocrinol. 2016; 77: 105-113.
  12. Schock H, Zeleniuch-Jacquotte A, Lundin E, Grankvist K, Hans-Ake L, Idahl A, et al. Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth. 2016; 16: 146.
  13. Pascual ZN, Langaker MD. Physiology, Pregnancy in StatPearls, Treasure Island (FL): StatPearls Publishing. 2022.
  14. Chaim W, Mazor M. The relationship between hormones and human parturition. Arch Gynecol Obstet. 1998; 262: 43-51.
  15. Parizek A, Koucky M, Duskova M. Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol. 2014; 139: 159-165.
  16. Gibb W, Challis JRG. Mechanisms of term and preterm birth. J Obstet Gynecol Can. 2002; 24: 874-883.
  17. Norman JE. Progesterone and preterm birth. Int J Gynecol Obstet. 2020; 150: 24-30.
  18. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008; 79: 50-57.
  19. Stjernholm-Vladic Y, Wang H, Stygar D, Ekman G, Sahlin L. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol. 2004; 18: 41-46.
  20. Ku CE, Allen JC, Lek SM, Chia ML, Tan NS, Tan TC. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study. BMC Pregnancy Childbirth. 2018; 18: 360.
  21. Deng Y, Chen C, Chen S, Mai G, Liao X, Tian H, et al. Baseline levels of serum progesterone and the first trimester pregnancy outcome in women with threatened abortion: A retrospective cohort study. BioMed Res Int. 2020; 8780253.
  22. Ku CW, Zhang X, Zhang VR, Allen JC, Tan NS, Ostbye T, et al. Gestational age-specific normative values and determinants of serum progesterone through the first trimester of pregnancy. Sci Rep. 2021; 11: 4161.
  23. Bobdiwala S, Kyriacou C, Christodoulou E, Farren J, Mitchell-Jones N, Al-Memar M, et al. Evaluating cut-off levels for progesterone, β human chorionic gonadotropin and β human chorionic gonadotropin ratio to exclude pregnancy viability in women with a pregnancy of unknown location: A prospective multicenter cohort study. Acta Obstet Gynecol Scand. 2022; 101: 46-55.
  24. Stampone E, Caldarelli I, Zullo A, Bencivenga D, Mancini FP, Ragione FD, et al. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases. Int J Mol Sci. 2018; 19.
  25. Hu XL, Shi S, Ning-Ning H, Meng Y, Li M, Ai-Xia L, et al. High maternal serum estradiol in first trimester of multiple pregnancy contributes to small for gestational age via DNMT1-Mediated CDKN1C upregulation. Reprod Sci Thousand Oaks Calif. 2022; 29: 1368-1378.
  26. Pappa C, Gkrozou F, Dimitriou E, Tsonis O, Kitsouli A, Varvarousis D, et al. Can maternal hormones play a significant role in delivery mode?. J Obstet Gynaecol. 2022; 42: 2779-2786.
  27. Boroditsky RS, Reyes FI, Winter JS, Faiman C. Maternal serum estrogen and progesterone concentrations preceding normal labor. Obstet Gynecol. 1978; 51: 686-691.
  28. Lofgren M, Backstrom T. High progesterone is related to effective human labor. Study of serum progesterone and 5alpha-pregnane-3,20-dione in normal and abnormal deliveries. Acta Obstet Gynecol Scand. 1997; 76: 423-430.
  29. Tan H, Yi L, Rote NS, Hurd WW, Mesiano S. Progesterone Receptor-A and -B Have opposite effects on proinflammatory gene expression in human myometrial cells: Implications for progesterone actions in human pregnancy and parturition. J Clin Endocrinol Metab. 2012; 97: E719– E730.
  30. Vrachnis N, Malamas FM, Sifakis S, Tsikouras P, Iliodromiti Z. Immune Aspects and Myometrial Actions of Progesterone and CRH in Labor. Clin Dev Immunol. 2012; 937618.
  31. Konopka CK, Morais EN, Naidon D, Pereira AM, Rubin MA, Oliveira JF, et al. Maternal serum progesterone, estradiol and estriol levels in successful dinoprostone-induced labor. Braz J Med Biol Res Rev. 2013; 46: 91-97.
  32. Mendelson CR. Minireview: Fetal-Maternal hormonal signaling in pregnancy and labor. Mol Endocrinol. 2009; 23: 947-954.
  33. Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN. Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Hum Reprod Update. 2016; 22: 535-560.
  34. Mears K, McAuliffe F, Grimes H, Morrison JJ. Fetal cortisol in relation to labour, intrapartum events and mode of delivery. J Obstet Gynaecol. J Inst Obstet Gynaecol. 2004; 24: 129-132.
  35. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998; 179: 194-202.
  36. Jung E, Romero R, Yeo L, Diaz-Primera R, Marin-Concha J, Para R, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998; 179: 186-193.
  37. Inserra PIF, Charif SE, Fidel V, Giacchino M, Schmidt AR, Villarreal FM, et al. The key action of estradiol and progesterone enables GnRH delivery during gestation in the South American plains vizcacha, Lagostomus maximus. J Steroid Biochem Mol Biol. 2020; 200: 105627.
  38. Ilicic M, Zakar T, Paul JW. Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium. BioMed Res Int. 2017; 4589214.